Form 8-K - Current report:
SEC Accession No. 0000950170-24-118586
Filing Date
2024-10-30
Accepted
2024-10-30 07:03:08
Documents
59
Period of Report
2024-10-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lrmr-20241030.htm   iXBRL 8-K 42840
2 EX-99.1 lrmr-ex99_1.htm EX-99.1 153099
3 EX-99.2 lrmr-ex99_2.htm EX-99.2 50518
4 GRAPHIC img46574298_0.jpg GRAPHIC 282533
5 GRAPHIC lrmr-ex99_2s1.jpg GRAPHIC 194227
6 GRAPHIC lrmr-ex99_2s2.jpg GRAPHIC 688560
7 GRAPHIC lrmr-ex99_2s3.jpg GRAPHIC 515232
8 GRAPHIC lrmr-ex99_2s4.jpg GRAPHIC 405506
9 GRAPHIC lrmr-ex99_2s5.jpg GRAPHIC 378376
10 GRAPHIC lrmr-ex99_2s6.jpg GRAPHIC 337680
11 GRAPHIC lrmr-ex99_2s7.jpg GRAPHIC 338124
12 GRAPHIC lrmr-ex99_2s8.jpg GRAPHIC 360482
13 GRAPHIC lrmr-ex99_2s9.jpg GRAPHIC 441542
14 GRAPHIC lrmr-ex99_2s10.jpg GRAPHIC 348359
15 GRAPHIC lrmr-ex99_2s11.jpg GRAPHIC 343072
16 GRAPHIC lrmr-ex99_2s12.jpg GRAPHIC 410730
17 GRAPHIC lrmr-ex99_2s13.jpg GRAPHIC 380853
18 GRAPHIC lrmr-ex99_2s14.jpg GRAPHIC 186194
19 GRAPHIC lrmr-ex99_2s15.jpg GRAPHIC 414067
20 GRAPHIC lrmr-ex99_2s16.jpg GRAPHIC 357442
21 GRAPHIC lrmr-ex99_2s17.jpg GRAPHIC 339416
22 GRAPHIC lrmr-ex99_2s18.jpg GRAPHIC 454113
23 GRAPHIC lrmr-ex99_2s19.jpg GRAPHIC 515329
24 GRAPHIC lrmr-ex99_2s20.jpg GRAPHIC 190931
25 GRAPHIC lrmr-ex99_2s21.jpg GRAPHIC 179821
26 GRAPHIC lrmr-ex99_2s22.jpg GRAPHIC 336425
27 GRAPHIC lrmr-ex99_2s23.jpg GRAPHIC 148370
28 GRAPHIC lrmr-ex99_2s24.jpg GRAPHIC 404994
29 GRAPHIC lrmr-ex99_2s25.jpg GRAPHIC 319752
30 GRAPHIC lrmr-ex99_2s26.jpg GRAPHIC 285154
31 GRAPHIC lrmr-ex99_2s27.jpg GRAPHIC 398077
32 GRAPHIC lrmr-ex99_2s28.jpg GRAPHIC 347335
33 GRAPHIC lrmr-ex99_2s29.jpg GRAPHIC 326145
34 GRAPHIC lrmr-ex99_2s30.jpg GRAPHIC 133667
35 GRAPHIC lrmr-ex99_2s31.jpg GRAPHIC 357327
36 GRAPHIC lrmr-ex99_2s32.jpg GRAPHIC 401974
37 GRAPHIC lrmr-ex99_2s33.jpg GRAPHIC 317815
38 GRAPHIC lrmr-ex99_2s34.jpg GRAPHIC 322386
39 GRAPHIC lrmr-ex99_2s35.jpg GRAPHIC 326094
40 GRAPHIC lrmr-ex99_2s36.jpg GRAPHIC 224767
41 GRAPHIC lrmr-ex99_2s37.jpg GRAPHIC 161013
42 GRAPHIC lrmr-ex99_2s38.jpg GRAPHIC 266122
43 GRAPHIC lrmr-ex99_2s39.jpg GRAPHIC 316340
44 GRAPHIC lrmr-ex99_2s40.jpg GRAPHIC 342025
45 GRAPHIC lrmr-ex99_2s41.jpg GRAPHIC 344664
46 GRAPHIC lrmr-ex99_2s42.jpg GRAPHIC 139398
47 GRAPHIC lrmr-ex99_2s43.jpg GRAPHIC 386380
48 GRAPHIC lrmr-ex99_2s44.jpg GRAPHIC 136652
49 GRAPHIC lrmr-ex99_2s45.jpg GRAPHIC 446153
  Complete submission text file 0000950170-24-118586.txt   21364234

Data Files

Seq Description Document Type Size
50 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lrmr-20241030.xsd EX-101.SCH 23893
61 EXTRACTED XBRL INSTANCE DOCUMENT lrmr-20241030_htm.xml XML 4533
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36510 | Film No.: 241407413
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)